Loading...
7 Immunodeficiencies Reports
Study Period: 2021 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Pharmacosmos AS, AMAG Pharmaceuticals Inc., Sanofi SA, AbbVie Inc., Fresenius SE & Co. KGaA
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Merck & Co., Inc. , Cipla Inc , Bristol-Myers Squibb Company, Viatris Inc. (Mylan), Johnson & Johnson
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Sanofi, AbbVie Inc. (Allergan Plc), Pharmacosmos A/S, Covis Pharma GmbH (AMAG Pharmaceuticals, Inc.), Pfizer Inc. (Global Blood Therapeutics, Inc.)
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Astellas Pharma, Inc, Bristol-Myers Squibb Company, Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Baxter international Inc, Takeda Pharmaceutical Company Limited, CSL Ltd, Octapharma AG, Biotest AG
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Marinus Pharmaceuticals, Zogenix, REGENXBIO, Longboard Pharmaceuticals, Ovid Therapeutics
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America, Global
Major Players: Novartis AG, Gilead Sciences, Inc (Kite Pharma), Dendreon Pharmaceuticals LLC, JW CreaGene Co., Ltd, GC Biopharma Corporation
Filter Reports
By Region
By Countries
